JADE1 and prostate carcinoma: Likewise for the TCGA dataset, lower levels of Jade-1 were associated with significantly poorer overall survival in lung adenocarcinoma and prostate cancer (https://www.proteinatlas.org/, accessed on 23 January 2023).